An Open-label, Randomized, Single-dose, 4-period, 4-sequence Crossover Relative Bioavailability Study Comparing Sotagliflozin Prototypes Tablets With Reference Tablet in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Sotagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 13 Dec 2017 Status changed from active, no longer recruiting to completed.
- 06 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Oct 2017 New trial record